Andrew is a General Partner at Pangaea Ventures, a world leader in advanced materials venture capital. He has a deep understanding of advanced materials commercialization and serves on the Editorial Board of the Journal, Translational Materials Research. In addition to Aspect Biosystems, Andrew serves on the board of CarbonCure Technologies, ESS Tech Inc., and Tivra Corporation. He previously served on the boards of RSI Inc. and Boulder Ionics which were sold in 2014. Andrew holds a Bachelor of Applied Science (Mechanical Engineering) from the University of Toronto and a MBA from the Sauder School of Business at the University of British Columbia.